Diagnostic Imaging Devices - Africa

The Diagnostic Imaging Devices market market in Africa is forecasted to achieve a revenue of US$1.03bn in 2024.
This revenue is projected to exhibit a compound annual growth rate (CAGR 2024-2029) of 5.07%, leading to a market volume of US$1.32bn by 2029.
When compared globally, the United States is anticipated to generate the highest revenue, amounting to US$11.93bn in 2024.
In Africa, the demand for advanced diagnostic imaging devices is rising to enhance healthcare services and improve patient outcomes.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in Africa is experiencing significant growth and development driven by customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Africa are shifting towards advanced diagnostic imaging devices that offer high-quality imaging, faster processing times, and improved patient comfort. As healthcare infrastructure improves and the demand for accurate and timely diagnostics increases, healthcare providers are investing in state-of-the-art imaging devices to meet these needs. Additionally, there is a growing demand for portable and compact imaging devices that can be easily transported to remote areas or used in mobile healthcare units. Trends in the market indicate a strong focus on technological advancements and innovation. Manufacturers are constantly introducing new imaging devices with enhanced features such as higher resolution, 3D imaging capabilities, and advanced software for image analysis. These advancements not only improve the accuracy of diagnoses but also increase the efficiency and productivity of healthcare providers. Furthermore, there is a growing trend towards the integration of imaging devices with electronic medical record systems, enabling seamless data transfer and analysis. Local special circumstances in Africa, such as a high burden of infectious diseases and limited access to healthcare facilities, contribute to the growth of the Diagnostic Imaging Devices market. Diagnostic imaging plays a crucial role in the detection and management of infectious diseases such as tuberculosis and HIV/AIDS. Additionally, the lack of healthcare infrastructure in many African countries necessitates the use of portable and mobile imaging devices to reach underserved populations. Underlying macroeconomic factors also play a significant role in the development of the Diagnostic Imaging Devices market in Africa. Economic growth and increasing disposable income levels in some African countries have led to higher healthcare spending and investments in healthcare infrastructure. Additionally, government initiatives to improve healthcare access and quality, such as the implementation of universal healthcare coverage, are driving the demand for diagnostic imaging devices. In conclusion, the Diagnostic Imaging Devices market in Africa is witnessing growth and development due to customer preferences for advanced imaging devices, trends towards technological advancements, local special circumstances, and underlying macroeconomic factors. As healthcare infrastructure continues to improve and the demand for accurate diagnostics increases, the market is expected to further expand in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.